The impact of a 1-hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure.

Analyses based on data collected from routine clinical care (Radboudumc) and the DIET study. The use of the patient data in future research is possible after a renewed permission by the patient as recorded in the informed consent (DIET) or after permission of the ethics committee of the patient’s treatment center. Since patients who were treated in other hospitals were included in this dataset, the current collection only contains used syntaxes for analyses and output data. The original data is stored at: H:\Vakgroep\Onderzoek\ONCO\AFGERONDE STUDIES\ONCO_PAZO_INNAMETIJD\Test analyse, the used analysis is version 7